ARCHIVES

In Brief: BMS Chemistry Awards to Honor Fu, Wood; Groshow Joins NCI; Bowman Moves to TJU

This article is from The Cancer Letter archive.

Vol. 25 No. 02 | January 15, 1999

Download PDF Visit The Full Archive

Related Articles

HCT Survivors More Likely To Show Heart Disease Risk Factors

October 26, 2012

Funding opportunities listed.

February 20, 2004

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

South Carolina Clinic and Anil Potti Part Ways

February 24, 2012

The Pink Machine Sputters, Goes in Reverse: Komen Funding Decision Sparks Outrage

February 3, 2012

Amgen Web Site For Patients Goes Dark After Story In The Cancer Letter.

November 16, 2007